New Journey Health Hits Day Low of CNY 2.31 Amid Price Pressure

New Journey Health Technology Group Co., Ltd. experienced a significant decline today, with the stock dropping by 6.07% and reaching an intraday low of CNY 2.31. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, New Journey has mirrored this downward trend, also declining by 6.07%. In the longer term, the stock has faced challenges, with a 15.33% decrease over the past year, while the China Shanghai Composite has gained 22.49%. The company's performance metrics reveal a concerning picture, with a net sales drop of 24.4% reported recently, alongside a high debt-to-equity ratio of 96.38%. Despite a year-to-date performance of 8.92%, the stock has consistently underperformed against its benchmark over the last three years, reflecting a broader struggle within the mid-cap pharmaceuticals and biotechnology sector. The company's return on equity stands at a modest 1.27%, and it carries a price-to-book ratio of 3.92, indicating a potentially expensive valuation relative to its book value.